Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial.
about
Emerging experience with meningococcal serogroup B protein vaccines.Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: a phase 3, open-label, randomized study.Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.
P2860
Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Immunogenicity and safety of c ...... , randomized controlled trial.
@en
Immunogenicity and safety of c ...... , randomized controlled trial.
@nl
type
label
Immunogenicity and safety of c ...... , randomized controlled trial.
@en
Immunogenicity and safety of c ...... , randomized controlled trial.
@nl
prefLabel
Immunogenicity and safety of c ...... , randomized controlled trial.
@en
Immunogenicity and safety of c ...... , randomized controlled trial.
@nl
P2093
P1433
P1476
Immunogenicity and safety of c ...... , randomized controlled trial.
@en
P2093
Daniela Toneatto
Eduardo Jorge da Fonseca Lima
Ilhem Mensi
Lily Yin Weckx
Marco Aurelio P Safadi
Marco Calabresi
P304
P356
10.1016/J.VACCINE.2017.03.002
P407
P577
2017-03-15T00:00:00Z